Archived Studies
These studies are closed and/or are currently not enrolling participants.
M22-128: EPICORE DLBCL-4
This study is now closed to participants. The M22-128 study is evaluating a combination of epcoritamab and lenalidomide for older adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), aiming to improve treatment outcomes and response rates.

